Evidence map›Paper›PMID 39010175›Full record

ArticleResearch involvement and engagement2024

Engagement and partnership with consumers and communities in the co-design and conduct of Research: Lessons from the INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis (INFERR) clinical trial.

Stephanie Long, Cheryl Ross, Joan Koops, Katherine Coulthard, Jane Nelson, Archana Khadka Shapkota, Leiana Hewett, Jaclyn Tate-Baker, Jessica Graham, Rose Mukula and 23 more

Abstract readLetter
In one paragraph

Article in Research involvement and engagement, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Stephanie Long *Division of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Cheryl Ross *Division of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Joan Koops *Top End INFERR Clinical Trial Indigenous Reference Group (The Top End Medical Iron Research and Study Advisory Group), Menzies School of Health Research, Northern Territory, Australia.
Katherine Coulthard *Central Australia INFERR Clinical Trial Indigenous Reference Group (The First Nations Iron Study Advisory Group - Central & Barkly), Menzies School of Health Research, Central Australia, Northern Territory, Australia.
Jane NelsonDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Archana Khadka ShapkotaDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Leiana HewettDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Jaclyn Tate-BakerNorthern Territory Department of Health, NT health, Northern Territory, Australia.
Jessica GrahamDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Rose MukulaDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Cynthia TettehDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Libby HoppoDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Sajiv CherianDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Basant PawarDepartment of Nephrology, Division of Medicine, Alice Springs Hospital, NT health, Alice Springs, Northern Territory, Australia.
Heidi Lee ChmielewskiNorthern Territory Department of Health, NT health, Northern Territory, Australia.
Lorna Murakami GoldFlinders University and Northern Territory Medical Program, Alice Springs Campus, Alice Springs, Northern Territory, Australia.
Geetha RathnayakeChemical Pathology-Territory Pathology, Department of Health, Northern Territory Government, Northern Territory, Australia.
Bianca HeronDepartment of Nephrology, Division of Medicine, Royal Darwin Hospital, NT Health, P.O. Box 41326, Northern Territory, Casuarina, Darwin, Australia.
Teana Brewster-O'BrienDepartment of Nephrology, Division of Medicine, Royal Darwin Hospital, NT Health, P.O. Box 41326, Northern Territory, Casuarina, Darwin, Australia.
Vijay KarepalliDepartment of Nephrology, Division of Medicine, Royal Darwin Hospital, NT Health, P.O. Box 41326, Northern Territory, Casuarina, Darwin, Australia.
Louise Maple-BrownDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Robert BateyNorthern Territory Department of Health, NT health, Northern Territory, Australia.
Peter MorrisChild Health Division, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Jane DaviesDepartment of Infectious Diseases, Division of Medicine, Royal Darwin Hospital, Northern Territory, Darwin, Australia.
David Kiran FernandesDepartment of Nephrology, Division of Medicine, Alice Springs Hospital, NT health, Alice Springs, Northern Territory, Australia.
Sajan ThomasDepartment of Nephrology, Division of Medicine, Alice Springs Hospital, NT health, Alice Springs, Northern Territory, Australia.
Asanga AbeyaratneDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Paul D LawtonDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Federica BarziDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Sean TaylorDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Mark MayoDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Alan CassDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.
Sandawana William MajoniDivision of Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia. sandawanaw@aol.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEngagement and partnership with consumers and communities throughout research processes produces high quality research meeting community needs and promoting translation of research into improved policy and practice. Partnership is critical in research involving Aboriginal and/or Torres Strait Islander people (First Nations Peoples) to ensure cultural safety. We present lessons from the design, implementation and progress of the National Health and Medical Research Council funded INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on hemodialysis (INFERR) clinical trial. MAIN BODY: The trial was designed to understand the benefits and harms of iron therapy in First Nations Australians on haemodialysis with anaemia and hyperferritinaemia. The lack of evidence for treatment was discussed with patients who were potential participants. A key element ensuring safe conduct of the INFERR trial was the establishment of the Indigenous Reference Groups (IRGs) comprising of dialysis patients based in the Top End of Australia and Central Australia. Two IRGs were needed based on advice from First Nations communities and researchers/academics on the project regarding local cultural differences and approaches to trial conduct. The IRGs underpin culturally safe trial conduct by providing input into study materials and translating study findings into effective messages and policies for First Nations dialysis patients. Throughout the trial conduct, the IRGs' role has developed to provide key mechanisms for advice and guidance regarding research conduct both in this study and more broadly. Support provided to the IRGs by trial First Nations Research Officers and independent First Nations researchers/academics who simplify research concepts is critical. The IRGs have developed feedback documents and processes to participants, stakeholders, and the renal units. They guarantee culturally safe advice for embedding findings from the trial into clinical practice guidelines ensuring evidence-based approaches in managing anaemia in haemodialysis patients with hyperferritinaemia.

conclusionActive consumer and community partnership is critical in research conduct to ensure research impact. Strong partnership with consumers in the INFERR clinical trial has demonstrated that First Nations Consumers will engage in research they understand, that addresses health priorities for them and where they feel respected, listened to, and empowered to achieve change.

Indexed as

Aboriginal and/or torres strait Islander peoplesClinical trialCommunitiesConsumersEngagementFirst nations peoplesHaemodialysisINFERRPartnershipReference groupsResearch

Identifiers

PMID39010175
PMCPMC11250943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.